Single cell mass spectrometry applied for multiparametric immune phenotyping with therapeutic implications in chronic lymphocytic leukemia (CLL)

Projekt: Forschung

Status	Abgeschlossen
Tatsächlicher Beginn/ -es Ende	24/05/19 → 24/05/21

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber, D. (Erstautor/-in), Qi, Y., Maeding, N., Steiner, M. (Co-Autor/-in), Denk, U. (Co-Autor/-in), Höpner, J. P., Hartmann, T. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2019, in: BLOOD . 134, 20, S. 1729
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

18 Quellenangaben (Web of Science)

Projektdetails